Global Fragment Based Drug Discovery Market is expected to grow at a CARG of 12.1% during the forecast period 2020-2027
A new research report published by Fior Markets with the title Fragment Based Drug Discovery Market by Type (Fragment Screening, Fragment Optimization), Application (Academic and Research Institutions, Biopharmaceutical Companies, Contract Research Organization), region, global industry analysis, market size, share, growth, trends, and forecast 2020 to 2027.
The global Fragment Based Drug Discovery market is expected to grow from USD 0.516 billion in 2019 to USD 1.23 billion by 2027, at a CARG of 12.1% during the forecast period 2020-2027. North America is dominating the market of fragment-based drug discovery and the demand in Asia-Pacific is increasing with a high pace compared to other regions. The Asia-Pacific demand increases due to, high investment in healthcare and infrastructure in China and India and increased focus on quality management. In North America region, U.S. dominates the fragment-based drug discovery market. In U.S. a team, CDER which comprises of statisticians, chemist, physician and other scientists, check, review and test, whether the drug is effective and safe for internal use or not.
DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/418388/request-sample
The key players of Fragment-based Drug Discovery market are, Evotec AG, Charles River Laboratories International, Crown Bioscience, Astex Pharmaceuticals, Sprint Bioscience, Kinetic Discovery Limited, Alveus Pharmaceuticals Pvt. Ltd.
Sprint Bioscience is advised to use its case wisely, as last year due to heavy investment the company ramped up its cash burn very fast and hard. The operation revenue also dropped and its free flow cash and revenue are working in wrong directions, it’s shareholders are wondering how the company is going to raise cash.
The type segment includes Fragment Screening, Fragment Optimization. The Fragment screening is sub-segmented into biophysical techniques and non-biophysical techniques. The biophysical technique includes, DSF assay, Surface Plasmon Resonance, Fluorescence Polarization (FP), NMR Spectroscopy, X-ray Crystallography, Isothermal Titration Calorimetry, Mass Spectrometry and other. X-ray crystallography and NMR Spectroscopy are the leading segments of this market. Fragment-based screening has appeared as a promising tool in drug discovery process and Fragment optimization is the most important step in the fragment-based drug discovery process. The application segment includes Academic and Research Institutions, Biopharmaceutical Companies, Contract Research Organization.
The fragment-based drug discovery market is experiencing a high demand due to problems faced in many complicated medical conditions. Its market is growing because of it’s time saving and easy access to fragment screening through biophysical techniques. The restrain this market gets, is when compounds have weak potency which is derived through fragment screening. Also, a smaller number of fragment libraries is another restrain to this market, as the libraries are helpful for conducting further research.
About the report:
The global Fragment Based Drug Discovery market is analyzed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on firstname.lastname@example.org or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
- CDN Newswire